| 0 |
INCREASED ANTEROPOSTERIOR CHEST DIAMETER |
1 |
0.1250 |
| 1 |
MONONUCLEAR CELL COUNT INCREASED |
1 |
0.0909 |
| 2 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING BY CHILD |
1 |
0.0476 |
| 3 |
PRURITUS ANI |
1 |
0.0169 |
| 4 |
CITROBACTER TEST POSITIVE |
1 |
0.0152 |
| 5 |
REFLUX NEPHROPATHY |
1 |
0.0152 |
| 6 |
RECTAL CANCER RECURRENT |
1 |
0.0118 |
| 7 |
OLIGODENDROGLIOMA |
1 |
0.0083 |
| 8 |
HERPES ZOSTER INFECTION NEUROLOGICAL |
1 |
0.0063 |
| 9 |
HYPERBARIC OXYGEN THERAPY |
1 |
0.0060 |
| 10 |
MALIGNANT NEOPLASM OF SPINAL CORD |
1 |
0.0055 |
| 11 |
PYELONEPHRITIS CHRONIC |
1 |
0.0053 |
| 12 |
CD8 LYMPHOCYTES DECREASED |
1 |
0.0050 |
| 13 |
PORTAL FIBROSIS |
1 |
0.0047 |
| 14 |
PROTEUS TEST POSITIVE |
1 |
0.0045 |
| 15 |
BIOPSY LIVER ABNORMAL |
1 |
0.0033 |
| 16 |
GENITAL PRURITUS FEMALE |
1 |
0.0031 |
| 17 |
DISTAL INTESTINAL OBSTRUCTION SYNDROME |
1 |
0.0030 |
| 18 |
HYPOCHROMIC ANAEMIA |
3 |
0.0030 |
| 19 |
CUBITAL TUNNEL SYNDROME |
1 |
0.0029 |
| 20 |
FAT EMBOLISM |
1 |
0.0028 |
| 21 |
SKIN TURGOR DECREASED |
1 |
0.0026 |
| 22 |
HEMIPARAESTHESIA |
1 |
0.0026 |
| 23 |
EXPOSURE VIA EYE CONTACT |
1 |
0.0024 |
| 24 |
COLONOSCOPY ABNORMAL |
1 |
0.0023 |
| 25 |
BONE DEBRIDEMENT |
1 |
0.0021 |
| 26 |
CHRONIC MYELOID LEUKAEMIA RECURRENT |
1 |
0.0018 |
| 27 |
LUNG INFECTION PSEUDOMONAL |
1 |
0.0018 |
| 28 |
RECTOCELE |
1 |
0.0017 |
| 29 |
VESTIBULAR DISORDER |
2 |
0.0016 |
| 30 |
BLOOD CORTISOL DECREASED |
1 |
0.0016 |
| 31 |
ABDOMINAL WALL ABSCESS |
1 |
0.0015 |
| 32 |
MACULAR FIBROSIS |
1 |
0.0015 |
| 33 |
T-LYMPHOCYTE COUNT DECREASED |
1 |
0.0015 |
| 34 |
FLUID IMBALANCE |
1 |
0.0014 |
| 35 |
SPUTUM INCREASED |
3 |
0.0014 |
| 36 |
NODAL RHYTHM |
2 |
0.0014 |
| 37 |
CHOLANGITIS ACUTE |
1 |
0.0013 |
| 38 |
TRACHEITIS |
1 |
0.0013 |
| 39 |
ADRENAL SUPPRESSION |
1 |
0.0012 |
| 40 |
OVARIAN CANCER METASTATIC |
1 |
0.0012 |
| 41 |
CRANIOFACIAL FRACTURE |
1 |
0.0012 |
| 42 |
SPINAL CORD NEOPLASM |
1 |
0.0011 |
| 43 |
ANAEMIA OF CHRONIC DISEASE |
1 |
0.0011 |
| 44 |
ACTINOMYCOSIS |
1 |
0.0010 |
| 45 |
EYELID PAIN |
2 |
0.0010 |
| 46 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 47 |
INFUSION SITE MASS |
1 |
0.0009 |
| 48 |
DRUG EXPOSURE VIA BREAST MILK |
1 |
0.0009 |
| 49 |
FACIAL SPASM |
1 |
0.0009 |
| 50 |
LIGAMENT INJURY |
1 |
0.0009 |
| 51 |
PRIAPISM |
3 |
0.0009 |
| 52 |
STAPHYLOCOCCAL SKIN INFECTION |
1 |
0.0008 |
| 53 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 54 |
ACROCHORDON |
1 |
0.0008 |
| 55 |
B-LYMPHOCYTE COUNT DECREASED |
1 |
0.0007 |
| 56 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
4 |
0.0007 |
| 57 |
RHONCHI |
1 |
0.0007 |
| 58 |
PRODUCT EXPIRATION DATE ISSUE |
1 |
0.0007 |
| 59 |
PRECANCEROUS CELLS PRESENT |
1 |
0.0007 |
| 60 |
SINUS ARREST |
1 |
0.0006 |
| 61 |
OPTIC NERVE DISORDER |
1 |
0.0006 |
| 62 |
EROSIVE OESOPHAGITIS |
1 |
0.0006 |
| 63 |
BILIARY DYSKINESIA |
1 |
0.0006 |
| 64 |
TREATMENT DELAYED |
1 |
0.0006 |
| 65 |
OTORRHOEA |
1 |
0.0006 |
| 66 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 67 |
KYPHOSIS |
1 |
0.0006 |
| 68 |
PANCREATIC FAILURE |
1 |
0.0006 |
| 69 |
HISTOPLASMOSIS |
1 |
0.0006 |
| 70 |
FIBRIN D DIMER INCREASED |
2 |
0.0006 |
| 71 |
DRUG WITHDRAWAL CONVULSIONS |
1 |
0.0006 |
| 72 |
PARAPARESIS |
1 |
0.0006 |
| 73 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 74 |
SINUS NODE DYSFUNCTION |
1 |
0.0005 |
| 75 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 76 |
PERONEAL NERVE PALSY |
3 |
0.0005 |
| 77 |
HYPERCOAGULATION |
1 |
0.0005 |
| 78 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 79 |
CHOLANGITIS SCLEROSING |
1 |
0.0005 |
| 80 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 81 |
CD4 LYMPHOCYTES DECREASED |
1 |
0.0005 |
| 82 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
2 |
0.0005 |
| 83 |
PULMONARY FUNCTION TEST DECREASED |
2 |
0.0005 |
| 84 |
PRODUCT LOT NUMBER ISSUE |
1 |
0.0005 |
| 85 |
GASTRIC POLYPS |
1 |
0.0004 |
| 86 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 87 |
ABNORMAL LOSS OF WEIGHT |
3 |
0.0004 |
| 88 |
READING DISORDER |
1 |
0.0004 |
| 89 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 90 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 91 |
INGROWING NAIL |
1 |
0.0004 |
| 92 |
SINUS OPERATION |
1 |
0.0004 |
| 93 |
FOOT OPERATION |
2 |
0.0004 |
| 94 |
EYELID IRRITATION |
1 |
0.0004 |
| 95 |
VASODILATATION |
1 |
0.0004 |
| 96 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 97 |
ENDODONTIC PROCEDURE |
1 |
0.0004 |
| 98 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 99 |
SERUM FERRITIN INCREASED |
2 |
0.0004 |
| 100 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 101 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 102 |
CREPITATIONS |
1 |
0.0003 |
| 103 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 104 |
RECTAL CANCER |
1 |
0.0003 |
| 105 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 106 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 107 |
FACET JOINT SYNDROME |
1 |
0.0003 |
| 108 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 109 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
2 |
0.0003 |
| 110 |
HEPATIC FIBROSIS |
1 |
0.0003 |
| 111 |
DIFFICULTY IN WALKING |
1 |
0.0003 |
| 112 |
THROMBOPHLEBITIS |
1 |
0.0003 |
| 113 |
APPENDICECTOMY |
1 |
0.0003 |
| 114 |
NEUTROPENIC SEPSIS |
2 |
0.0003 |
| 115 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 116 |
DENTAL CARIES |
3 |
0.0003 |
| 117 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 118 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 119 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 120 |
THYROID MASS |
1 |
0.0003 |
| 121 |
WOUND SECRETION |
1 |
0.0003 |
| 122 |
PRODUCT USE COMPLAINT |
4 |
0.0003 |
| 123 |
RENAL CYST |
2 |
0.0003 |
| 124 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 125 |
STENT PLACEMENT |
2 |
0.0002 |
| 126 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 127 |
PERIPHERAL ISCHAEMIA |
1 |
0.0002 |
| 128 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 129 |
SECOND PRIMARY MALIGNANCY |
2 |
0.0002 |
| 130 |
ONYCHOMADESIS |
1 |
0.0002 |
| 131 |
LIP OEDEMA |
1 |
0.0002 |
| 132 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 133 |
MONOPLEGIA |
1 |
0.0002 |
| 134 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 135 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 136 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 137 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 138 |
RHEUMATIC FEVER |
1 |
0.0002 |
| 139 |
EAR DISORDER |
1 |
0.0002 |
| 140 |
ISCHAEMIA |
1 |
0.0002 |
| 141 |
ROSACEA |
1 |
0.0002 |
| 142 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 143 |
FINGER DEFORMITY |
1 |
0.0002 |
| 144 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 145 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 146 |
BLADDER DISORDER |
2 |
0.0002 |
| 147 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 148 |
TOE AMPUTATION |
1 |
0.0002 |
| 149 |
CACHEXIA |
1 |
0.0002 |
| 150 |
SKIN NECROSIS |
1 |
0.0002 |
| 151 |
MALABSORPTION |
1 |
0.0002 |
| 152 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 153 |
FOOD POISONING |
1 |
0.0002 |
| 154 |
GINGIVITIS |
1 |
0.0002 |
| 155 |
STRESS FRACTURE |
1 |
0.0002 |
| 156 |
NORMAL NEWBORN |
1 |
0.0002 |
| 157 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 158 |
MACULAR OEDEMA |
1 |
0.0002 |
| 159 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 160 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 161 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 162 |
RALES |
1 |
0.0002 |
| 163 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 164 |
DECREASED INTEREST |
1 |
0.0002 |
| 165 |
DRUG ABUSER |
1 |
0.0002 |
| 166 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 167 |
BLEPHAROSPASM |
1 |
0.0002 |
| 168 |
PHOTOPSIA |
1 |
0.0002 |
| 169 |
SCREAMING |
1 |
0.0002 |
| 170 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 171 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 172 |
BREAST CANCER STAGE III |
1 |
0.0002 |
| 173 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 174 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 175 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 176 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 177 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 178 |
BRONCHIECTASIS |
1 |
0.0001 |
| 179 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 180 |
CORONARY ARTERY OCCLUSION |
2 |
0.0001 |
| 181 |
LYMPHOEDEMA |
1 |
0.0001 |
| 182 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 183 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 184 |
APHONIA |
2 |
0.0001 |
| 185 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 186 |
DIVERTICULUM |
1 |
0.0001 |
| 187 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 188 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
0.0001 |
| 189 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 190 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 191 |
ARTHROPOD BITE |
1 |
0.0001 |
| 192 |
DUODENAL ULCER PERFORATION |
1 |
0.0001 |
| 193 |
MUSCULOSKELETAL PAIN |
7 |
0.0001 |
| 194 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 195 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 196 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 197 |
HAEMOLYSIS |
1 |
0.0001 |
| 198 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 199 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 200 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 201 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 202 |
RESPIRATORY TRACT CONGESTION |
2 |
0.0001 |
| 203 |
OBESITY |
2 |
0.0001 |
| 204 |
SENSORY LOSS |
1 |
0.0001 |
| 205 |
DECUBITUS ULCER |
1 |
0.0001 |
| 206 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 207 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 208 |
MUSCLE INJURY |
1 |
0.0001 |
| 209 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 210 |
LIVE BIRTH |
1 |
0.0001 |
| 211 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 212 |
MUSCLE STRAIN |
1 |
0.0001 |
| 213 |
PYELONEPHRITIS |
1 |
0.0001 |
| 214 |
NAIL DISORDER |
1 |
0.0001 |
| 215 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 216 |
COLD SWEAT |
2 |
0.0001 |
| 217 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 218 |
HAEMARTHROSIS |
1 |
0.0001 |
| 219 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 220 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 221 |
LIP DRY |
1 |
0.0001 |
| 222 |
BONE DISORDER |
2 |
0.0001 |
| 223 |
EXOSTOSIS |
1 |
0.0001 |
| 224 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 225 |
LACERATION |
1 |
0.0001 |
| 226 |
FOOT FRACTURE |
2 |
0.0001 |
| 227 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 228 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 229 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 230 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 231 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 232 |
SKIN FISSURES |
2 |
0.0001 |
| 233 |
COELIAC DISEASE |
1 |
0.0001 |
| 234 |
HEPATOMEGALY |
1 |
0.0001 |
| 235 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 236 |
HOSPICE CARE |
1 |
0.0001 |
| 237 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 238 |
HYPOTONIA |
1 |
0.0001 |
| 239 |
OVARIAN CYST |
1 |
0.0001 |
| 240 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 241 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 242 |
EYELID PTOSIS |
1 |
0.0001 |
| 243 |
TOOTH ABSCESS |
1 |
0.0001 |
| 244 |
SLUGGISHNESS |
1 |
0.0001 |
| 245 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 246 |
HELICOBACTER INFECTION |
1 |
0.0001 |
| 247 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 248 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 249 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 250 |
EYE DISCHARGE |
1 |
0.0001 |
| 251 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 252 |
FOLLICULITIS |
1 |
0.0001 |
| 253 |
INCONTINENCE |
1 |
0.0001 |
| 254 |
JOINT DISLOCATION |
1 |
0.0001 |
| 255 |
JOINT INJURY |
2 |
0.0001 |
| 256 |
NIGHT SWEATS |
3 |
0.0001 |
| 257 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 258 |
BACK INJURY |
1 |
0.0001 |
| 259 |
WOUND INFECTION |
1 |
0.0001 |
| 260 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 261 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 262 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 263 |
EYE PAIN |
5 |
0.0001 |
| 264 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 265 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 266 |
SPLENOMEGALY |
1 |
0.0001 |
| 267 |
SPINAL PAIN |
1 |
0.0001 |
| 268 |
WHEEZING |
5 |
0.0001 |
| 269 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 270 |
HEPATITIS C |
1 |
0.0001 |
| 271 |
BURSITIS |
1 |
0.0001 |
| 272 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 273 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 274 |
ILEUS |
1 |
0.0001 |
| 275 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 276 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 277 |
PEMPHIGUS |
1 |
0.0001 |
| 278 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 279 |
CELLULITIS |
4 |
0.0001 |
| 280 |
COLITIS |
3 |
0.0001 |
| 281 |
ANOREXIA |
1 |
0.0001 |
| 282 |
SPEECH DISORDER |
4 |
0.0001 |
| 283 |
HAND DEFORMITY |
1 |
0.0001 |
| 284 |
INCORRECT PRODUCT STORAGE |
1 |
0.0001 |
| 285 |
TOOTH INFECTION |
1 |
0.0001 |
| 286 |
ADVERSE REACTION |
1 |
0.0001 |
| 287 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 288 |
SINUS CONGESTION |
1 |
0.0001 |
| 289 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 290 |
BLISTER |
4 |
0.0001 |
| 291 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 292 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 293 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 294 |
MUSCULAR WEAKNESS |
8 |
0.0001 |
| 295 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 296 |
HYPERSOMNIA |
2 |
0.0001 |
| 297 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 298 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 299 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 300 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 301 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 302 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 303 |
INSURANCE ISSUE |
1 |
0.0001 |
| 304 |
FEELING HOT |
4 |
0.0001 |
| 305 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 306 |
ULCER |
1 |
0.0001 |
| 307 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 308 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 309 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 310 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 311 |
PERICARDITIS |
1 |
0.0001 |
| 312 |
DELIRIUM |
2 |
0.0001 |
| 313 |
SYRINGE ISSUE |
1 |
0.0001 |
| 314 |
BRADYCARDIA |
3 |
0.0001 |
| 315 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 316 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 317 |
GOUT |
1 |
0.0001 |
| 318 |
SYNOVITIS |
1 |
0.0001 |
| 319 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 320 |
WHITE BLOOD CELL COUNT DECREASED |
6 |
0.0001 |
| 321 |
TOOTHACHE |
1 |
0.0001 |
| 322 |
OSTEOMYELITIS |
1 |
0.0001 |
| 323 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 324 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 325 |
DYSURIA |
2 |
0.0001 |
| 326 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 327 |
BRONCHITIS |
4 |
0.0001 |
| 328 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 329 |
EYE SWELLING |
2 |
0.0001 |
| 330 |
URTICARIA |
9 |
0.0001 |
| 331 |
NECK PAIN |
3 |
0.0001 |
| 332 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 333 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 334 |
PHOTOPHOBIA |
1 |
0.0001 |
| 335 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 336 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 337 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 338 |
FRACTURE |
1 |
0.0001 |
| 339 |
PULMONARY EMBOLISM |
5 |
0.0001 |
| 340 |
INSOMNIA |
14 |
0.0001 |
| 341 |
DEHYDRATION |
7 |
0.0001 |
| 342 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 343 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 344 |
PRODUCT SUBSTITUTION ISSUE |
3 |
0.0001 |
| 345 |
CHOLESTASIS |
1 |
0.0001 |
| 346 |
HERNIA |
1 |
0.0001 |
| 347 |
VISION BLURRED |
7 |
0.0001 |
| 348 |
KIDNEY INFECTION |
1 |
0.0001 |
| 349 |
MEMORY IMPAIRMENT |
7 |
0.0001 |
| 350 |
SINUS DISORDER |
1 |
0.0001 |
| 351 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 352 |
DISORIENTATION |
2 |
0.0001 |
| 353 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 354 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 355 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 356 |
TASTE DISORDER |
1 |
0.0000 |
| 357 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 358 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 359 |
SINUSITIS |
5 |
0.0000 |
| 360 |
TOOTH LOSS |
1 |
0.0000 |
| 361 |
POLLAKIURIA |
2 |
0.0000 |
| 362 |
DERMATITIS |
1 |
0.0000 |
| 363 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 364 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 365 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 366 |
BALANCE DISORDER |
4 |
0.0000 |
| 367 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 368 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 369 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 370 |
MELAENA |
1 |
0.0000 |
| 371 |
LIVER DISORDER |
2 |
0.0000 |
| 372 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 373 |
GLOSSODYNIA |
1 |
0.0000 |
| 374 |
THROAT IRRITATION |
2 |
0.0000 |
| 375 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 376 |
CHROMATURIA |
1 |
0.0000 |
| 377 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 378 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 379 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 380 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 381 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 382 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 383 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 384 |
INJURY |
3 |
0.0000 |
| 385 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 386 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 387 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 388 |
MOBILITY DECREASED |
3 |
0.0000 |
| 389 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 390 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 391 |
CONTUSION |
4 |
0.0000 |
| 392 |
FIBROMYALGIA |
1 |
0.0000 |
| 393 |
PRESYNCOPE |
1 |
0.0000 |
| 394 |
URINARY TRACT INFECTION |
7 |
0.0000 |
| 395 |
LIVER INJURY |
1 |
0.0000 |
| 396 |
DYSPEPSIA |
4 |
0.0000 |
| 397 |
ABASIA |
1 |
0.0000 |
| 398 |
AGEUSIA |
1 |
0.0000 |
| 399 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 400 |
FLUSHING |
4 |
0.0000 |
| 401 |
HEPATITIS |
1 |
0.0000 |
| 402 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 403 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 404 |
RASH GENERALISED |
1 |
0.0000 |
| 405 |
HAEMATOMA |
1 |
0.0000 |
| 406 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 407 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 408 |
DEAFNESS |
1 |
0.0000 |
| 409 |
GASTRITIS |
1 |
0.0000 |
| 410 |
EAR INFECTION |
1 |
0.0000 |
| 411 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 412 |
PAIN OF SKIN |
1 |
0.0000 |
| 413 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 414 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 415 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 416 |
DRY MOUTH |
3 |
0.0000 |
| 417 |
ANAEMIA |
7 |
0.0000 |
| 418 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 419 |
DIVERTICULITIS |
1 |
0.0000 |
| 420 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 421 |
ARTHROPATHY |
2 |
0.0000 |
| 422 |
HAEMOPTYSIS |
1 |
0.0000 |
| 423 |
PANCYTOPENIA |
2 |
0.0000 |
| 424 |
WOUND |
1 |
0.0000 |
| 425 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 426 |
HYPONATRAEMIA |
2 |
0.0000 |
| 427 |
ASTHMA |
4 |
0.0000 |
| 428 |
PAIN IN JAW |
1 |
0.0000 |
| 429 |
DEPRESSION |
8 |
0.0000 |
| 430 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 431 |
ANGINA PECTORIS |
1 |
0.0000 |
| 432 |
PYREXIA |
12 |
0.0000 |
| 433 |
NEEDLE ISSUE |
1 |
0.0000 |
| 434 |
DYSSTASIA |
1 |
0.0000 |
| 435 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 436 |
CATARACT |
2 |
0.0000 |
| 437 |
HYPOAESTHESIA |
5 |
0.0000 |
| 438 |
HEPATIC FAILURE |
1 |
0.0000 |
| 439 |
FALL |
11 |
0.0000 |
| 440 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 441 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 442 |
EPILEPSY |
1 |
0.0000 |
| 443 |
INJECTION SITE RASH |
1 |
0.0000 |
| 444 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 445 |
CHEST PAIN |
6 |
0.0000 |
| 446 |
FEMUR FRACTURE |
1 |
0.0000 |
| 447 |
WEIGHT DECREASED |
9 |
0.0000 |
| 448 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 449 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 450 |
DYSPNOEA |
18 |
0.0000 |
| 451 |
MIGRAINE |
3 |
0.0000 |
| 452 |
CYSTITIS |
1 |
0.0000 |
| 453 |
MOOD SWINGS |
1 |
0.0000 |
| 454 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 455 |
HIP FRACTURE |
1 |
0.0000 |
| 456 |
CONFUSIONAL STATE |
5 |
0.0000 |
| 457 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 458 |
PAIN IN EXTREMITY |
9 |
0.0000 |
| 459 |
IMPAIRED HEALING |
1 |
0.0000 |
| 460 |
OSTEONECROSIS |
1 |
0.0000 |
| 461 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 462 |
DECREASED APPETITE |
7 |
0.0000 |
| 463 |
TREMOR |
5 |
0.0000 |
| 464 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 465 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 466 |
ABDOMINAL PAIN |
7 |
0.0000 |
| 467 |
VIRAL INFECTION |
1 |
0.0000 |
| 468 |
SYNCOPE |
3 |
0.0000 |
| 469 |
URINARY RETENTION |
1 |
0.0000 |
| 470 |
GAIT INABILITY |
1 |
0.0000 |
| 471 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 472 |
MALAISE |
13 |
0.0000 |
| 473 |
HAEMATURIA |
1 |
0.0000 |
| 474 |
MULTIPLE SCLEROSIS RELAPSE |
2 |
0.0000 |
| 475 |
GASTRIC DISORDER |
1 |
0.0000 |
| 476 |
DEVICE USE ERROR |
1 |
0.0000 |
| 477 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 478 |
BURNING SENSATION |
2 |
0.0000 |
| 479 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 480 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 481 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 482 |
PNEUMONIA |
9 |
0.0000 |
| 483 |
CRYING |
1 |
0.0000 |
| 484 |
UNDERDOSE |
2 |
0.0000 |
| 485 |
MUSCLE SPASMS |
5 |
0.0000 |
| 486 |
INJECTION SITE MASS |
1 |
0.0000 |
| 487 |
INFLUENZA |
3 |
0.0000 |
| 488 |
SEPSIS |
3 |
0.0000 |
| 489 |
DYSARTHRIA |
1 |
0.0000 |
| 490 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 491 |
NAUSEA |
21 |
0.0000 |
| 492 |
DIARRHOEA |
17 |
0.0000 |
| 493 |
HOSPITALISATION |
4 |
0.0000 |
| 494 |
SEIZURE |
3 |
0.0000 |
| 495 |
VOMITING |
12 |
0.0000 |
| 496 |
ALOPECIA |
5 |
0.0000 |
| 497 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 498 |
CARDIAC FAILURE |
2 |
0.0000 |
| 499 |
JOINT SWELLING |
3 |
0.0000 |
| 500 |
SOMNOLENCE |
5 |
0.0000 |
| 501 |
DYSKINESIA |
1 |
0.0000 |
| 502 |
FATIGUE |
19 |
0.0000 |
| 503 |
CARDIAC ARREST |
2 |
0.0000 |
| 504 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 505 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 506 |
DIZZINESS |
12 |
0.0000 |
| 507 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 508 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 509 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 510 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 511 |
HYPOACUSIS |
1 |
0.0000 |
| 512 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 513 |
SEPTIC SHOCK |
1 |
0.0000 |
| 514 |
MENTAL DISORDER |
1 |
0.0000 |
| 515 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 516 |
TACHYCARDIA |
2 |
0.0000 |
| 517 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 518 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 519 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 520 |
NEUTROPENIA |
3 |
0.0000 |
| 521 |
SKIN IRRITATION |
1 |
0.0000 |
| 522 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 523 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 524 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 525 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 526 |
SWELLING |
2 |
0.0000 |
| 527 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 528 |
DYSPHAGIA |
2 |
0.0000 |
| 529 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 530 |
HEADACHE |
13 |
0.0000 |
| 531 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 532 |
LUNG DISORDER |
1 |
0.0000 |
| 533 |
PRODUCT DOSE OMISSION ISSUE |
6 |
0.0000 |
| 534 |
LEUKOPENIA |
1 |
0.0000 |
| 535 |
HYPOTENSION |
4 |
0.0000 |
| 536 |
FLUID RETENTION |
1 |
0.0000 |
| 537 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 538 |
INFLAMMATION |
1 |
0.0000 |
| 539 |
HAEMORRHAGE |
2 |
0.0000 |
| 540 |
PARAESTHESIA |
3 |
0.0000 |
| 541 |
DEPRESSED MOOD |
1 |
0.0000 |
| 542 |
DRUG INTERACTION |
3 |
0.0000 |
| 543 |
HYPERTENSION |
4 |
0.0000 |
| 544 |
ASTHENIA |
7 |
0.0000 |
| 545 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 546 |
RASH |
8 |
0.0000 |
| 547 |
PAIN |
11 |
0.0000 |
| 548 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 549 |
COUGH |
5 |
0.0000 |
| 550 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 551 |
MYALGIA |
3 |
0.0000 |
| 552 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 553 |
CONVULSION |
1 |
0.0000 |
| 554 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 555 |
BACK PAIN |
4 |
0.0000 |
| 556 |
COVID-19 |
3 |
0.0000 |
| 557 |
DYSPHONIA |
1 |
0.0000 |
| 558 |
PALPITATIONS |
2 |
0.0000 |
| 559 |
BONE PAIN |
1 |
0.0000 |
| 560 |
CHILLS |
2 |
0.0000 |
| 561 |
NASAL CONGESTION |
1 |
0.0000 |
| 562 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 563 |
ARTHRALGIA |
7 |
0.0000 |
| 564 |
FEELING ABNORMAL |
4 |
0.0000 |
| 565 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 566 |
STOMATITIS |
1 |
0.0000 |
| 567 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 568 |
VERTIGO |
1 |
0.0000 |
| 569 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 570 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 571 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 572 |
HYPERHIDROSIS |
2 |
0.0000 |
| 573 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 574 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 575 |
DRUG INEFFECTIVE |
20 |
0.0000 |
| 576 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 577 |
DRY SKIN |
2 |
0.0000 |
| 578 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 579 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 580 |
ERYTHEMA |
3 |
0.0000 |
| 581 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 582 |
SLEEP DISORDER |
1 |
0.0000 |
| 583 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 584 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 585 |
CONSTIPATION |
3 |
0.0000 |
| 586 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 587 |
WEIGHT INCREASED |
3 |
0.0000 |
| 588 |
EPISTAXIS |
1 |
0.0000 |
| 589 |
HALLUCINATION |
1 |
0.0000 |
| 590 |
HOT FLUSH |
1 |
0.0000 |
| 591 |
DIABETES MELLITUS |
1 |
0.0000 |
| 592 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 593 |
PRURITUS |
5 |
0.0000 |
| 594 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 595 |
THROMBOSIS |
1 |
0.0000 |
| 596 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 597 |
TREATMENT FAILURE |
1 |
0.0000 |
| 598 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 599 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 600 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 601 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 602 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 603 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 604 |
DEVICE ISSUE |
1 |
0.0000 |
| 605 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 606 |
ADVERSE EVENT |
1 |
0.0000 |
| 607 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 608 |
BREAST CANCER |
1 |
0.0000 |
| 609 |
CARDIAC DISORDER |
1 |
0.0000 |
| 610 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 611 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 612 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 613 |
HEART RATE INCREASED |
1 |
0.0000 |
| 614 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 615 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 616 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 617 |
ILLNESS |
1 |
0.0000 |
| 618 |
DEATH |
8 |
0.0000 |
| 619 |
OVERDOSE |
2 |
0.0000 |
| 620 |
OFF LABEL USE |
8 |
0.0000 |
| 621 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 622 |
PSORIASIS |
1 |
0.0000 |
| 623 |
RENAL FAILURE |
1 |
0.0000 |
| 624 |
ANXIETY |
2 |
0.0000 |
| 625 |
INFECTION |
1 |
0.0000 |
| 626 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 627 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 628 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 629 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 630 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 631 |
INJECTION SITE PAIN |
1 |
0.0000 |